Delivery Order SPE2DB22D3301-SPE2DB25FX9AL
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,834.97 firm fixed-price delivery order is for Gadavist 10 mmol/10 ml vials. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Gadavist, a bulk pharmaceutical product. The contract is a delivery order with a firm fixed price of $1,242.58 and an ultimate completion date of January 31, 2025. The contract is not designated as a set-aside and represents a broader indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,884.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Gadavist 10 mmol/10 ml vial (10 ml). This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award, valued at $1,538.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 ml vial of a 10 mmol/ml concentration medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,337.79 firm fixed-price delivery order is for the supply of 4565188888 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has an ultimate completion date of July 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Gadavist, a pharmaceutical product, with a ceiling value of $1,062.40 and an ultimate completion date of January 21, 2025. The contract is a firm-fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,513.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GADAVIST 15 MMOL/15 ML VIAL 15ML, a medical commodity with a completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,037.81 firm fixed-price delivery order is for the supply of Gadavist, a medical imaging agent, with a period of performance through November 15, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Gadavist 10 mmol/10 ml vials. The $4,729.46 order has a completion date of January 30, 2024 and does not fall under any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award is for the supply of the pharmaceutical product Gadavist (7.5 mmol/7.5 ml vial, 7.5 ml) to the Defense Logistics Agency (DLA). The $1,071.13 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...